Speakers: AxoSim Lead Scientist of Assay Development and Screening Andrew LaCroix, PhD | AxoSim Director of Corporate and Business Development Amit […]
microBrain™ Deep Dive | Highlighting Disease Modeling Read more
Speaker: AxoSim’s Newest Scientists Andrew LaCroix, PhD and Nicholas Coungeris | AxoSim Co-Founder and CEO J. Lowry Curley, PhD AxoSim webinar: Functional
Speakers: Martina de Majo, PhD, Director or Research & Development at Synpaticure and Jaime Hatcher-Martin, MD, PhD, Movement Disorders Director Synapticure.
Speaker: Patrick M Dougherty, Professor of Pain Medicine | MD Anderson Cancer Center Take an in-depth look at Dr. Dougherty’s innovative
“Human DRG studies on ectopic spontaneous activity” with Dr. Pat Dougherty of MD Anderson Read more
Human NerveSim® from AxoSim Speaker: Megan Terral, Scientific Projects Manager, AxoSim Preclinical animal models are historically expensive and low-throughput, and have
Human NerveSim®: A 3D In Vitro Nerve-on-a-Chip Model for Preclinical Drug Screening Read more
Speaker: Thomas Hartung, MD, PhD, Consulting VP of Scientific Affairs at AxoSim and Professor and Chair, Johns Hopkins University Neurological impairments
Translating Neurological Stem Cell Research into Therapies for Today’s Patients Read more
Speaker: J. Lowry Curley, PhD, Co-Founder and CEO of AxoSim Take an in-depth look at AxoSim’s case study on chemotherapeutic drug
Scaling Peripheral Nerves: A Case Study on CIPN Read more
Speaker: Rakesh Dixit, PhD, DABT, President and CEO, Bionavigen Peripheral Neuropathy is a common side effect of many Antibody Drug Conjugates.
ADCs and Peripheral Neuropathy: The Need for New, Predictive Assays Read more
Speakers: Helena Hogberg, PhD, Deputy Director of Center for Alternatives to Animal Testing at Johns Hopkins University Bloomberg School of Public
Nervesim™ and Brainsim™: Platforms for Neurological Drug Discovery and Toxicology Read more
